Alternative Splicing in Epilepsy and Alzheimer's Disease
Author Information
Author(s): Heinzen Erin L, Yoon Woohyun, Weale Michael E, Sen Arjune, Wood Nicholas W, Burke James R, Welsh-Bohmer Kathleen A, Hulette Christine M, Sisodiya Sanjay M, Goldstein David B
Primary Institution: Duke University
Hypothesis
This work sought to identify disease-associated alternative splicing patterns in ion channel genes by screening affected brain tissue from patients with mesial temporal lobe epilepsy and Alzheimer's disease.
Conclusion
The study identified a set of disease-associated, alternatively spliced gene products that are priorities for further investigation into their roles in mesial temporal lobe epilepsy and Alzheimer's disease.
Supporting Evidence
- 25% of genes showed significant splicing changes in mesial temporal lobe epilepsy.
- 12% of genes showed significant splicing changes in Alzheimer's disease.
- Real-time PCR confirmed 9 out of 13 splice events identified by the microarray.
Takeaway
Scientists looked at brain samples from people with epilepsy and Alzheimer's to find out how genes are spliced differently in these diseases, which could help us understand them better.
Methodology
The study used a novel microarray technology to screen for alternative splice variants and confirmed findings with real-time quantitative PCR.
Potential Biases
Potential bias due to differences in tissue collection methods and the variability in patient demographics.
Limitations
The study may have missed some splicing events due to the complexity of splicing changes and the limitations of the microarray technology.
Participant Demographics
Patients with mesial temporal lobe epilepsy aged 18-60 years, and Alzheimer's disease patients aged 79-90 years.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website